Search research articles
Contact Us
Filters
Showing results (51-60 of 329) with videos related to
Page
of 33
Sort By:
Lung
|
July 23, 2013
Immune diffuse alveolar hemorrhage: a retrospective assessment of a diagnostic scale
Nicolas de Prost, Antoine Parrot, Elise Cuquemelle, et al.
European Radiology
|
April 20, 2006
Primary pulmonary artery aneurysm in tuberous sclerosis: CT, angiography and pathological study
Marie-France Carette, Martine Antoine, Bernard Bazelly, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 2, 2008
Gefitinib-associated Propionibacterium acnes pleural empyema
Nicolas de Prost, Armelle Lavolé, Laurent Taillade, et al.
Bulletin Du Cancer
|
December 4, 2016
[Perioperative therapies in surgical non N2 non-small cell lung cancer]
Anne-Marie Ruppert, Armelle Lavolé, Jalal Assouad, et al.
Translational Lung Cancer Research
|
June 19, 2025
Sacituzumab govitecan: a new hope for patients with pretreated extensive small-cell lung cancer (SCLC)-insights from the TROPiCS-03 trial
Baptiste Abbar, Frank Aboubakar Nana, Jean Philippe Spano, et al.
Bulletin Du Cancer
|
April 25, 2012
[Which platform to support a personalized lung cancer treatment?]
Anne-Marie Ruppert, Martine Antoine, Michèle Beau-Faller, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
October 21, 2021
Lung cancer is also a hereditary disease
Patrick R Benusiglio, Vincent Fallet, Mateo Sanchis-Borja, et al.
Annales De Pathologie
|
November 9, 2010
[Pretreatment molecular biology analysis on small size biopsies]
Martine Antoine, Virginie Poulot, Magali Colombat, et al.
Revue De Pneumologie Clinique
|
September 6, 2005
[Drug-associated interstitial lung disease: a diagnostic challenge]
Charles Mayaud, Muriel Fartoukh, Antoine Parrot, et al.
The European Respiratory Journal
|
June 23, 2018
Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times
Sandrine Loubière, Fabrice Barlesi, Pascale Missy, et al.
Page
of 33
Search research articles
Search
Showing results (51-60 of 329) with videos related to
Sort By:
Page
of 33
Lung
|
July 23, 2013
Immune diffuse alveolar hemorrhage: a retrospective assessment of a diagnostic scale
Nicolas de Prost, Antoine Parrot, Elise Cuquemelle, et al.
European Radiology
|
April 20, 2006
Primary pulmonary artery aneurysm in tuberous sclerosis: CT, angiography and pathological study
Marie-France Carette, Martine Antoine, Bernard Bazelly, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 2, 2008
Gefitinib-associated Propionibacterium acnes pleural empyema
Nicolas de Prost, Armelle Lavolé, Laurent Taillade, et al.
Bulletin Du Cancer
|
December 4, 2016
[Perioperative therapies in surgical non N2 non-small cell lung cancer]
Anne-Marie Ruppert, Armelle Lavolé, Jalal Assouad, et al.
Translational Lung Cancer Research
|
June 19, 2025
Sacituzumab govitecan: a new hope for patients with pretreated extensive small-cell lung cancer (SCLC)-insights from the TROPiCS-03 trial
Baptiste Abbar, Frank Aboubakar Nana, Jean Philippe Spano, et al.
Bulletin Du Cancer
|
April 25, 2012
[Which platform to support a personalized lung cancer treatment?]
Anne-Marie Ruppert, Martine Antoine, Michèle Beau-Faller, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
October 21, 2021
Lung cancer is also a hereditary disease
Patrick R Benusiglio, Vincent Fallet, Mateo Sanchis-Borja, et al.
Annales De Pathologie
|
November 9, 2010
[Pretreatment molecular biology analysis on small size biopsies]
Martine Antoine, Virginie Poulot, Magali Colombat, et al.
Revue De Pneumologie Clinique
|
September 6, 2005
[Drug-associated interstitial lung disease: a diagnostic challenge]
Charles Mayaud, Muriel Fartoukh, Antoine Parrot, et al.
The European Respiratory Journal
|
June 23, 2018
Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times
Sandrine Loubière, Fabrice Barlesi, Pascale Missy, et al.
Page
of 33